Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial
Revista Española de Cardiología (English Edition) · 2026-06 · 79 (6) · 522-533
DOI: 10.1016/j.rec.2025.12.008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2026-06. Verfasst von Eduardo Flores-Umanzor und 13 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Cardiología, Instituto Cardiovascular, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelo…. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Platelet Aggregation Inhibitors, Anticoagulants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Bristol-Myers Squibb.
Abstract (Originalsprache)
INTRODUCTION AND OBJECTIVES: The ADALA trial showed a more favorable efficacy-safety profile with low-dose direct oral anticoagulation (LD-DOAC) vs dual antiplatelet therapy (DAPT) at 3 months after left atrial appendage occlusion (LAAO). However, outcomes after switching both regimens to single antiplatelet therapy (SAPT) remain uncertain. This study reports the 1-year results, focusing on outcomes after the switch to SAPT. METHODS: The ADALA trial was a multicenter, randomized clinical trial that enrolled 91 patients with atrial fibrillation and contraindications to oral anticoagulation. After successful LAAO, participants were randomized to receive LD-DOAC or DAPT for 3 months, after which all patients transitioned to SAPT. The primary endpoint was a composite of thromboembolic events, device-related thrombus (DRT), or major bleeding at 1-year. RESULTS: At 12 months, the primary endpoint was significantly lower in the LD-DOAC group compared with the DAPT group (9.1% vs 32.6%; HR, 0.25; 95%CI, 0.08-0.74; P=.013), mainly driven by a reduction in DRT (0% vs 11.6%; P=.023). Major bleeding was numerically lower with LD-DOAC (9.1% vs 19.6%; P=.167), and total bleeding events were significantly reduced (13.6% vs 37.0%; P=.013). Landmark analysis showed significant differences during the initial 3 months (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Cardiología, Instituto Cardiovascular, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain.
- Departamento de Cardiología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (C…
- Departamento de Cardiología, Hospital Universitario de la Santa Creu i Sant Pau, IIB Sant Pau, Barcelona, Spain.
- Departamento de Cardiología, Instituto Cardiovascular, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain; Quebec Heart and Lung Institute, Laval University, Quebec C…
- Departamento de Cardiología, Instituto Cardiovascular, Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain. Electronic address: freixa@clinic.cat.
Förderung
- Bristol-Myers Squibb
Zitieren
APA
Flores-Umanzor, E., Cruz-González, I., Cepas-Guillén, P., Millán, X., Antúnez-Muiños, P., Asmarats, L., Laffond, A., Regueiro, A., López-Tejero, S., Li, C. P., Sanchis, L., Rodés-Cabau, J., Arzamendi, D., & Freixa, X. (2026). Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial. Revista Española de Cardiología (English Edition), 79(6), 522-533. https://doi.org/10.1016/j.rec.2025.12.008
Vancouver
Flores-Umanzor E, Cruz-González I, Cepas-Guillén P, Millán X, Antúnez-Muiños P, Asmarats L, et al. Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial. Revista Española de Cardiología (English Edition). 2026;79(6):522-533. doi:10.1016/j.rec.2025.12.008
BibTeX
@article{FloresUmanzor2026,
author = {Flores-Umanzor, Eduardo and Cruz-González, Ignacio and Cepas-Guillén, Pedro and Millán, Xavi and Antúnez-Muiños, Pablo and Asmarats, Lluís and Laffond, Ana and Regueiro, Ander and López-Tejero, Sergio and Li, Chi-Hion Pedro and Sanchis, Laura and Rodés-Cabau, Josep and Arzamendi, Dabit and Freixa, Xavier},
title = {Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: 1-year results from the ADALA trial},
journal = {Revista Española de Cardiología (English Edition)},
year = {2026},
volume = {79},
number = {6},
pages = {522--533},
doi = {10.1016/j.rec.2025.12.008}
}
EUVIMED